Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |